Nuveen’s Krystal Biotech KRYS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$37M Sell
143,368
-45,726
-24% -$12.2M 0.01% 788
2025
Q4
$46.6M Sell
189,094
-8,284
-4% -$1.74M 0.01% 685
2025
Q3
$34.8M Buy
197,378
+9,359
+5% +$1.4M 0.01% 800
2025
Q2
$25.8M Sell
188,019
-46,161
-20% -$6.78M 0.01% 940
2025
Q1
$42.2M Sell
234,180
-69,935
-23% -$11.8M 0.01% 695
2024
Q4
$47.6M Sell
304,115
-7,740
-2% -$1.37M 0.01% 671
2024
Q3
$56.8M Sell
311,855
-24,315
-7% -$4.69M 0.02% 598
2024
Q2
$61.7M Buy
336,170
+5,728
+2% +$962K 0.02% 542
2024
Q1
$58.8M Buy
330,442
+14,977
+5% +$2.08M 0.02% 576
2023
Q4
$39.1M Buy
315,465
+53,231
+20% +$5.9M 0.01% 729
2023
Q3
$30.4M Buy
262,234
+111,395
+74% +$13.6M 0.01% 793
2023
Q2
$17.7M Buy
150,839
+97,908
+185% +$10M 0.01% 1153
2023
Q1
$4.24M Sell
52,931
-4,481
-8% -$352K ﹤0.01% 1984
2022
Q4
$4.55M Sell
57,412
-27,913
-33% -$2.07M ﹤0.01% 1967
2022
Q3
$5.95M Sell
85,325
-31
-0% -$2.24K ﹤0.01% 1800
2022
Q2
$5.6M Buy
85,356
+1,097
+1% +$68.2K ﹤0.01% 1874
2022
Q1
$5.64M Buy
84,259
+6,081
+8% +$380K ﹤0.01% 1991
2021
Q4
$5.47M Sell
78,178
-4,122
-5% -$240K ﹤0.01% 2066
2021
Q3
$4.3M Buy
82,300
+14,090
+21% +$834K ﹤0.01% 2298
2021
Q2
$4.64M Buy
68,210
+15,914
+30% +$1.11M ﹤0.01% 2294
2021
Q1
$4.03M Buy
52,296
+4,105
+9% +$298K ﹤0.01% 2269
2020
Q4
$2.89M Buy
48,191
+1,217
+3% +$60.8K ﹤0.01% 2324
2020
Q3
$2.02M Buy
46,974
+2,774
+6% +$120K ﹤0.01% 2383
2020
Q2
$1.83M Buy
44,200
+2,524
+6% +$121K ﹤0.01% 2373
2020
Q1
$1.8M Buy
41,676
+2,189
+6% +$114K ﹤0.01% 2242
2019
Q4
$2.19M Sell
39,487
-1,145
-3% -$56.2K ﹤0.01% 2387
2019
Q3
$1.41M Buy
40,632
+5,450
+15% +$244K ﹤0.01% 2548
2019
Q2
$1.42M Buy
+35,182
New +$1.15M ﹤0.01% 2592

Other funds holding KRYS